G. Touloumi et al., Estimation and comparison of rates of change in longitudinal studies with informative drop-outs, STAT MED, 18(10), 1999, pp. 1215-1233
Citations number
33
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Many cohort studies and clinical trials have designs which involve repeated
measurements of disease markers. One problem in such longitudinal studies,
when the primary interest is to estimate and to compare the evolution of a
disease marker, is that planned data are not collected because of missing
data due to missing visits and/or withdrawal or attrition (for example, dea
th). Several methods to analyse such data are available, provided that the
data are missing at random. However, serious biases can occur when missingn
ess is informative. In such cases, one needs to apply methods that simultan
eously model the observed data and the missingness process. In this paper w
e consider the problem of estimation of the rate of change of a disease mar
ker in longitudinal studies, in which some subjects drop out prematurely (i
nformatively) due to attrition, while others experience a non-informative d
rop-out process (end of study, withdrawal). We propose a method which combi
nes a linear random effects model for the underlying pattern of the marker
with a log-normal survival model for the informative drop-out process. Join
t estimates are obtained through the restricted iterative generalized least
squares method which are equivalent to restricted maximum likelihood estim
ates. A nested EM algorithm is applied to deal with censored survival data.
The advantages of this method are: it provides a unified approach to estim
ate all the model parameters; it can effectively deal with irregular data (
that is, measured at irregular time points), a complicated covariance struc
ture and a complex underlying profile of the response variable; it does not
entail such complex computation as would be required to maximize the joint
likelihood. The method is illustrated by modelling CD4 count data in a cli
nical trial in patients with advanced HIV infection while its performance i
s tested by simulation studies. Copyright (C) 1999 John Wiley & Sons, Ltd.